Ken Griffin Senti Biosciences, Inc. Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.36 - $0.66 $12,708 - $23,299
35,302 Added 80.78%
79,005 $30,000
Q4 2023

Feb 14, 2024
BUY
$0.28 - $0.68 $12,236 - $29,718
43,703 New
43,703 $28,000

Others Institutions Holding SNTI

# of Institutions
3
Shares Held
342K
Call Options Held
0
Put Options Held
0
View Full List

About Senti Biosciences, Inc.

SNTI Quotes by TradingView
  • Ticker SNTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,757,100
  • Market Cap $172M
  • Description
  • Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...
More about SNTI
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email